SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300,704 | -54.6% | 501,341 | -1.7% | 0.00% | – |
| Q2 2023 | $662,792 | -24.7% | 509,840 | +1.9% | 0.00% | – |
| Q1 2023 | $880,231 | -43.7% | 500,132 | +0.4% | 0.00% | – |
| Q4 2022 | $1,564,140 | -37.8% | 498,134 | -3.0% | 0.00% | -100.0% |
| Q3 2022 | $2,516,000 | +31.6% | 513,493 | +11.2% | 0.00% | – |
| Q2 2022 | $1,912,000 | -25.8% | 461,908 | +4.2% | 0.00% | – |
| Q1 2022 | $2,576,000 | -21.8% | 443,190 | +0.9% | 0.00% | -100.0% |
| Q4 2021 | $3,294,000 | -16.1% | 439,155 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $3,928,000 | -18.9% | 436,097 | +7.7% | 0.00% | 0.0% |
| Q2 2021 | $4,846,000 | -21.1% | 404,823 | -17.4% | 0.00% | 0.0% |
| Q1 2021 | $6,139,000 | -22.6% | 489,886 | -3.7% | 0.00% | -50.0% |
| Q4 2020 | $7,935,000 | +58.7% | 508,502 | -3.9% | 0.00% | +100.0% |
| Q3 2020 | $4,999,000 | +2.7% | 528,951 | -2.7% | 0.00% | 0.0% |
| Q2 2020 | $4,869,000 | +48.5% | 543,485 | +5.6% | 0.00% | 0.0% |
| Q1 2020 | $3,278,000 | -23.0% | 514,645 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $4,259,000 | -8.1% | 508,787 | -0.6% | 0.00% | 0.0% |
| Q3 2019 | $4,633,000 | -14.9% | 511,881 | +1.3% | 0.00% | 0.0% |
| Q2 2019 | $5,442,000 | +21.5% | 505,256 | +7.6% | 0.00% | 0.0% |
| Q1 2019 | $4,478,000 | -15.9% | 469,447 | +1.3% | 0.00% | -50.0% |
| Q4 2018 | $5,323,000 | -30.9% | 463,645 | +2.0% | 0.00% | 0.0% |
| Q3 2018 | $7,708,000 | +21.4% | 454,735 | +1.7% | 0.00% | 0.0% |
| Q2 2018 | $6,351,000 | -27.9% | 447,263 | -3.6% | 0.00% | 0.0% |
| Q1 2018 | $8,814,000 | +36.9% | 463,848 | +18.1% | 0.00% | 0.0% |
| Q4 2017 | $6,440,000 | +14.7% | 392,713 | +4.9% | 0.00% | 0.0% |
| Q3 2017 | $5,614,000 | +87.8% | 374,309 | +10.1% | 0.00% | +100.0% |
| Q2 2017 | $2,990,000 | +72.6% | 339,842 | +2.0% | 0.00% | – |
| Q1 2017 | $1,732,000 | +80.8% | 333,305 | +6.1% | 0.00% | – |
| Q4 2016 | $958,000 | -34.2% | 314,163 | -0.0% | 0.00% | – |
| Q3 2016 | $1,455,000 | -92.5% | 314,241 | -90.6% | 0.00% | -100.0% |
| Q2 2016 | $19,318,000 | -4.9% | 3,336,541 | -0.7% | 0.01% | 0.0% |
| Q1 2016 | $20,324,000 | +17.6% | 3,359,331 | +77.5% | 0.01% | +20.0% |
| Q4 2015 | $17,280,000 | +57.3% | 1,892,738 | -2.8% | 0.01% | +66.7% |
| Q3 2015 | $10,984,000 | -47.3% | 1,947,623 | +3.6% | 0.00% | -50.0% |
| Q2 2015 | $20,848,000 | -25.1% | 1,879,927 | +6.0% | 0.01% | -14.3% |
| Q1 2015 | $27,818,000 | +16.7% | 1,774,071 | +13.2% | 0.01% | +16.7% |
| Q4 2014 | $23,846,000 | +503.5% | 1,567,892 | +328.0% | 0.01% | +500.0% |
| Q3 2014 | $3,951,000 | -64.9% | 366,314 | -50.4% | 0.00% | -50.0% |
| Q2 2014 | $11,270,000 | +78.2% | 737,992 | +110.9% | 0.00% | 0.0% |
| Q1 2014 | $6,325,000 | +43.3% | 349,890 | +10.1% | 0.00% | +100.0% |
| Q4 2013 | $4,415,000 | -25.0% | 317,813 | -43.3% | 0.00% | 0.0% |
| Q3 2013 | $5,886,000 | +188.1% | 561,010 | +114.4% | 0.00% | 0.0% |
| Q2 2013 | $2,043,000 | – | 261,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |